Cholera toxin B subunit-Five-stranded α-helical coiled-coil fusion protein: "Five-to-five" molecular chimera displays robust physicochemical stability

Vaccine

Volumn 32, Issue 39, 2014, Pages 5019-5026

  Arakawa, Takeshi ^a   Harakuni, Tetsuya ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

Cartilage oligomeric matrix protein; Cholera toxin B subunit; Physicochemical stability; Rational design of vaccines; Helical coiled coil

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHOLERA TOXIN B SUBUNIT; DODECYL SULFATE SODIUM; HYBRID PROTEIN; IMMUNOGLOBULIN G; WATER; BACTERIUM ANTIBODY; CHOLERA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MELTING POINT; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PHYSICAL CHEMISTRY; PICHIA PASTORIS; PRIORITY JOURNAL; THERMOSTABILITY; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; IMMUNOLOGY; PROTEIN STABILITY; PROTEIN TERTIARY STRUCTURE;

ANIMALS; ANTIBODIES, BACTERIAL; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHOLERA TOXIN; FEMALE; IMMUNOGLOBULIN G; MICE, INBRED BALB C; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS;

EID: 84906096847     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.07.016     Document Type: Article

References (31)

1. Clemens J.D., Sack D.A., Harris J.R., Chakraborty J., Khan M.R., Stanton B.F., et al. Field trial of oral cholera vaccines in Bangladesh. Lancet 1986, 2:124-127.
2. Ahren C., Wenneras C., Holmgren J., Svennerholm A.M. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine. Vaccine 1993, 11:929-934.
3. Sun J.B., Mielcarek N., Lakew M., Grzych J.M., Capron A., Holmgren J., et al. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. J Immunol (Baltimore, MD: 1950) 1999, 163:1045-1052.
4. Holmgren J., Adamsson J., Anjuere F., Clemens J., Czerkinsky C., Eriksson K., et al. Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 2005, 97:181-188.
5. Harakuni T., Sugawa H., Komesu A., Tadano M., Arakawa T. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect Immun 2005, 73:5654-5665.
6. Miyata T., Harakuni T., Tsuboi T., Sattabongkot J., Kohama H., Tachibana M., et al. Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization. Infect Immun 2010, 78:3773-3782.
7. Miyata T., Harakuni T., Taira T., Matsuzaki G., Arakawa T. Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice. Vaccine 2012, 30:948-958.
8. Zhang R.G., Westbrook M.L., Westbrook E.M., Scott D.L., Otwinowski Z., Maulik P.R., et al. The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid. J Mol Biol 1995, 251:550-562.
9. Shamini G., Ravichandran M., Sinnott J.T., Somboonwit C., Sidhu H.S., Shapshak P., et al. Structural inferences for Cholera toxin mutations in Vibrio cholerae. Bioinformation 2011, 6:1-9.
10. Dalziel A.W., Lipka G., Chowdhry B.Z., Sturtevant J.M., Schafer D.E. Effects of ganglioside GM1 on the thermotropic behavior of cholera toxin B subunit. Mol Cell Biochem 1984, 63:83-91.
11. Goins B., Freire E. Thermal stability and intersubunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1. Biochemistry 1988, 27:2046-2052.
12. Bhakuni V., Xie D., Freire E. Thermodynamic identification of stable folding intermediates in the B-subunit of cholera toxin. Biochemistry 1991, 30:5055-5060.
13. Lesieur C., Cliff M.J., Carter R., James R.F., Clarke A.R., Hirst T.R. A kinetic model of intermediate formation during assembly of cholera toxin B-subunit pentamers. J Biol Chem 2002, 277:16697-16704.
14. Brandau D.T., Jones L.S., Wiethoff C.M., Rexroad J., Middaugh C.R. Thermal stability of vaccines. J Pharm Sci 2003, 92:218-231.
15. Kristensen D., Chen D., Cummings R. Vaccine stabilization: research, commercialization, and potential impact. Vaccine 2011, 29:7122-7124.
16. Miyata T., Oshiro S., Harakuni T., Taira T., Matsuzaki G., Arakawa T. Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks. Vaccine 2012, 30:4225-4232.
17. Oldberg A., Antonsson P., Lindblom K., Heinegard D. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992, 267:22346-22350.
18. Hedbom E., Antonsson P., Hjerpe A., Aeschlimann D., Paulsson M., Rosa-Pimentel E., et al. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992, 267:6132-6136.
19. Morgelin M., Heinegard D., Engel J., Paulsson M. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 1992, 267:6137-6141.
20. Efimov V.P., Lustig A., Engel J. The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83. FEBS Lett 1994, 341:54-58.
21. Efimov V.P., Engel J., Malashkevich V.N. Crystallization and preliminary crystallographic study of the pentamerizing domain from cartilage oligomeric matrix protein: a five-stranded alpha-helical bundle. Proteins 1996, 24:259-262.
22. Malashkevich V.N., Kammerer R.A., Efimov V.P., Schulthess T., Engel J. The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel?. Science (New York, NY) 1996, 274:761-765.
23. Lupas A.N., Gruber M. The structure of alpha-helical coiled coils. Adv Protein Chem 2005, 70:37-78.
24. Guo Y., Kammerer R.A., Engel J. The unusually stable coiled-coil domain of COMP exhibits cold and heat denaturation in 4-6M guanidinium chloride. Biophys Chem 2000, 85:179-186.
25. Miyata T., Harakuni T., Tsuboi T., Sattabongkot J., Ikehara A., Tachibana M., et al. Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development. Infect Immun 2011, 79:4260-4275.
26. Stein P.E., Boodhoo A., Tyrrell G.J., Brunton J.L., Read R.J. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 1992, 355:748-750.
27. Fraser M.E., Fujinaga M., Cherney M.M., Melton-Celsa A.R., Twiddy E.M., O'Brien A.D., et al. Structure of shiga toxin type 2 (Stx2) from Escherichia coli O157:H7. J Biol Chem 2004, 279:27511-27517.
28. Fraser M.E., Chernaia M.M., Kozlov Y.V., James M.N. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5A resolution. Nat Struct Biol 1994, 1:59-64.
29. Sixma T.K., Pronk S.E., Kalk K.H., Wartna E.S., van Zanten B.A., Witholt B., et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 1991, 351:371-377.
30. Sixma T.K., Kalk K.H., van Zanten B.A., Dauter Z., Kingma J., Witholt B., et al. Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin. J Mol Biol 1993, 230:890-918.
31. Kitova E.N., Daneshfar R., Marcato P., Mulvey G.L., Armstrong G., Klassen J.S. Stability of the homopentameric B subunits of shiga toxins 1 and 2 in solution and the gas phase as revealed by nanoelectrospray Fourier transform ion cyclotron resonance mass spectrometry. J Am Soc Mass Spectrom 2005, 16:1957-1968.